Canyon Laboratories, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Canyon Laboratories, LLC - overview

Established

2020

Location

Bluffdale, UT, US

Primary Industry

Pharmaceuticals

About

Established in 2020 and based in Utah, US, Canyon Laboratories, LLC provides specialized laboratory testing and consulting services for the medical device and pharmaceutical sectors, ensuring compliance with industry regulations and facilitating product development. In May 2023, Canyon Labs was acquired by MedVenture Health. The firm’s core offerings include microbiology and sterility assurance, analytical chemistry, packaging testing, and biocompatibility and toxicology assessments. These services are designed to ensure compliance with industry standards, facilitating the testing process from initial development stages to full production for various medical products.


Canyon Labs primarily serves a diverse clientele that includes medical device manufacturers, pharmaceutical companies, and other stakeholders within the healthcare sector.   Canyon Labs generates revenue through direct business-to-business transactions, focusing on service agreements with clients in the medical and pharmaceutical sectors. The transaction structure typically involves clients contracting for specific testing services, such as biocompatibility assessments or analytical chemistry analysis.   The recent acquisition by MedVenture Health in May 2023 is expected to drive Canyon Laboratories into its next stage of growth, expanding its service offerings.


Canyon Labs plans to leverage this acquisition to enhance existing services and potentially develop new testing solutions tailored to client needs.


Current Investors

Wasatch Health

Primary Industry

Pharmaceuticals

Sub Industries

Consulting Services, Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development

Website

www.canyonlabs.com/

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Canyon Laboratories, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Corporate Carve Out, Trade SaleCompletediuvo BioScience's Lab Services and Consulting Businesses-
BuyoutCompletedCanyon Laboratories, LLC-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.